Insider · CIK 0001704234

Doogan Declan

Reports to the SEC for 2 companies · CHAPEL HILL, NC

sec.gov

Transactions

Companies

Filings

CIK

0001704234

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	TENXTENAX THERAPEUTICS, INC.P Purchase	Director	PPurchase	+53K sh	$1.92	+$102K	55,274
2026-01-09	TENXTENAX THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-07-01	TENXTENAX THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2024-12-10	TENXTENAX THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-08-11	TENXTENAX THERAPEUTICS, INC.G Gift	Director	GGift	−568K sh	—	—	0
2022-08-11	TENXTENAX THERAPEUTICS, INC.G Gift	Director	GGift	+568K sh	—	—	3,637,871
2022-06-09	TENXTENAX THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-11-30	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+5,475 sh	—	—	632,987
2021-11-30	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−5,475 sh	—	—	0
2021-11-29	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−13K sh	$112.40	−$1.46M	882,147
2021-11-29	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−11.5K sh	$113.25	−$1.3M	870,648
2021-11-22	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+491K sh	—	—	627,512
2021-11-22	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−491K sh	—	—	5,475
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−250K sh	—	—	0
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+175K sh	$5.60	+$980K	798,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$9.29	+$464K	848,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−12.4K sh	$115.90	−$1.44M	920,476
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$47.10	+$848K	932,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$10.82	+$325K	914,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$28.76	+$518K	866,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+250K sh	$0.61	+$153K	623,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−18.2K sh	$116.69	−$2.13M	902,246
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−175K sh	—	—	0
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	0
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$61.76	+$1.11M	884,913
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−7,073 sh	$117.87	−$834K	895,173
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2021-11-16	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2021-10-14	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+7,342 sh	—	—	7,342
2021-10-14	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−7,342 sh	—	—	180,318
2021-10-14	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+7,015 sh	—	—	136,252
2021-10-14	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−7,015 sh	—	—	0
2021-06-30	TENXTENAX THERAPEUTICS, INC.G Gift	Director	GGift	−568K sh	—	—	2,502,129
2021-06-11	TENXTENAX THERAPEUTICS, INC. · Series B Preferred StockM Exercise/Conversion	Director	MExercise/Conversion	−3,070 sh	—	—	0
2021-06-11	TENXTENAX THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3.07M sh	—	—	3,637,871
2021-06-10	TENXTENAX THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+6,250 sh	—	—	6,250
2021-05-21	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−20.8K sh	—	—	0
2021-05-21	Biohaven Pharmaceutical Holding Co Ltd.I Discretionary Transaction	Director	IDiscretionary Transaction	+170K sh	—	—	187,660
2021-05-21	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+20.8K sh	—	—	129,237
2021-05-21	Biohaven Pharmaceutical Holding Co Ltd.I Discretionary Transaction	Director	IDiscretionary Transaction	−170K sh	—	—	108,437
2021-05-18	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−31.5K sh	—	—	20,800
2021-05-18	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+20.8K sh	—	—	52,340
2021-05-18	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−20.8K sh	—	—	17,660
2021-05-18	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+31.5K sh	—	—	278,437
2021-05-18	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+114K sh	—	—	246,897
2021-05-18	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	−114K sh	—	—	496,735
2021-05-05	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	11,996
2021-03-24	Biohaven Pharmaceutical Holding Co Ltd.G Gift	Director	GGift	+133K sh	—	—	132,985

Recent filings

Accepted (ET)
Sep 174
Doogan Declan0001193125-26-394831
SEC(opens sec.gov)
Jan 134
Doogan Declan0001704234-26-000001
SEC(opens sec.gov)
Jul 34
Doogan Declan0001654954-25-007737
SEC(opens sec.gov)
Dec 124
Doogan Declan0001654954-24-015473
SEC(opens sec.gov)
Aug 124
Doogan Declan0001654954-22-011198
SEC(opens sec.gov)
Jun 104
Doogan Declan0001654954-22-008235
SEC(opens sec.gov)
Feb 115
Doogan Declan0001562180-22-001436
SEC(opens sec.gov)
Feb 114/A
Doogan Declan0001562180-22-001434
SEC(opens sec.gov)
Feb 114/A
Doogan Declan0001562180-22-001435
SEC(opens sec.gov)

Companies

Address

101 GLEN LENNOX DRIVE, SUITE 300

CHAPEL HILL, NC, 27517